Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Elizabeth Orr
AdvaMed has revised its industry Code of Ethics. The revised code, which will come into effect in 2020, includes new sections on off-label communications and training health-care professionals to use new medical technology.
Edwards Lifesciences and Boston Scientific announced this week that the firms had resolved an ongoing global patent dispute.
Recently inaugurated Mexican President Andrés Manuel López Obrador campaigned on a promise to tackle the country’s corruption issues. Medtech Insight spoke to attorney Nicholas Berg, of Ropes & Gray, about what this may mean for device manufacturers doing business in Mexico.
The Fifth Circuit Court of Appeals has rejected former ArthroCare CEO Michael Baker’s appeal of a 20-year sentence. Baker was convicted on charges related to a $750m fraud case.
A law firm has filed a class action suit against the US Department of Health and Human Services trying to force broader Medicare reimbursement of continuous glucose monitors. Currently, federal health programs will only cover specific types and uses of the diabetes treatment technology.
US FDA has granted a de novo clearance to Bruin Biometrics’ SEM Scanner, which is the first device cleared to assess parts of a patient’s body that may be at risk for pressure ulcers.